Boston Scientific (NYSE: BSX) today shared study data supporting the use of its Eluvia drug-eluting stent for treating PAD.

Cook Medical today announced a collaboration with Mendaera to create solutions for needle-based interventions with handheld ...

Most recently, Eskandanian led a pediatric medtech innovation collaboration between Children’s National and Compremium, which ...

NeuroOne (Nasdaq:NMTC) announced today that it filed an FDA 510(k) submission for its trigeminal nerve ablation technology.

A medical team at the Amsterdam University Medical Centre (AUMC) in the Netherlands completed the first-in-human ventricular ...

Artedrone says preclinical studies show its Sasha microbotic system can autonomously perform mechanical thrombectomy for ...

Epiminder announced that it received FDA de novo authorization for its implantable continuous electroencephalogram monitoring ...

CereVasc announced today that it received FDA breakthrough device designation for its investigational eShunt system.

Boston Scientific (NYSE: BSX) shares ticked up before hours today on first-quarter results that topped the consensus forecast ...

Surgical stock fell despite beating expectations as the company warned Trump's import taxes could have a significant impact.

BD (NYSE: BDX) announced today that it received FDA 510(k) clearance for its Phasix ST umbilical hernia patch.

R3 Vascular announced that a doctor treated the first patient in the ELITE-BTK pivotal trial of its drug-eluting ...